Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
| Status: | Completed |
|---|---|
| Conditions: | Cosmetic |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 1/1/2014 |
| Start Date: | February 2013 |
| End Date: | December 2015 |
| Contact: | Marilou Cramer, BS |
| Email: | mcramer@revance.com |
| Phone: | 510-742-3497 |
This study will evaluate the long-term safety of botulinum toxin type A for the treatment of
moderate to severe crow's feet lines after repeat application.
moderate to severe crow's feet lines after repeat application.
Inclusion Criteria:
- Moderate to severe crow's feet lines
- Female or male, 18 to 70 years of age and in good general health
- Women of childbearing potential must agree to use an effective method of birth
control during the course of the study
Exclusion Criteria:
- Any neurological condition that may place the subject at increased risk with exposure
to botulinum toxin type A
- Muscle weakness or paralysis, particularly in the area receiving study treatment
- Active skin disease or irritation at the treatment area
- Deep dermal scarring, or inability to smooth out the crow's feet lines to be treated
by manually spreading the skin apart
- Treatment with botulinum toxin type A for crow's feet lines in the last 3 months
- Chemical peel during the 9 months prior to treatment
- Use of prescription retinoid products during the 3 months prior to treatment
We found this trial at
1
site
Click here to add this to my saved trials
